Company profile

Neuromedical Systems, Inc.

Neuromedical Systems, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on November 8, 1995 and the most recent on November 8, 1995 (PAPNET Testing System). Its most common review panel is Pathology (1 device).

1AI devices
1995First decision
1995Latest decision
1Specialties

Timeline

  1. PAPNET Testing System · Pathology · MNM